Cuba confirms registration of vaccine against lung cancer in Belarus
- Written by Redacción ¡ahora!
- Published in Health
- Hits: 1401
The registration in Belarus of the first therapeutic vaccine against lung cancer shows the results reaped on July 14th by the biotechnological and pharmaceutical sector, despite the US blockade, assured the member of the Political Bureau of the Party and Chancellor, Bruno Rodríguez Parrilla.
In his X account, the head of that portfolio confirmed the news, recently disclosed, which reported the registration in the Eurasian nation of the Cimavax vaccine, developed by the Center for Molecular Immunology of Cuba.
Rodriguez Parrilla highlighted the merit of the national biotechnological and pharmaceutical sector, which, he said, continues to reap great results, despite the difficulties imposed by the tightening of the U.S. blockade against the Caribbean nation.
A report by the Prensa Latina news agency, dated July 12 in Minsk, the capital of Belarus, informed that the Belarusian Ministry of Health, through its Center for Health Care Testing and Expertise, granted the registration of the Cuban vaccine Cimavax.
The drug was the world's first officially patented and registered therapeutic vaccine against lung cancer, reports the news source.
The decision of the Slavic nation's regulatory agency is an indisputable achievement of Cuban biotechnology in a country with such high and demanding standards as Belarus, commented the Cuban ambassador in Minsk, Santiago Pérez.
Likewise, the European country was the first in that continent to register the Cuban vaccine Soberana, developed against COVID-19, recalled the head of the diplomatic legation of the Caribbean island.
According to the ambassador, this registration also shows the progress of bilateral relations, specifically in the economic-commercial area that would allow an increase in exports to Cuba.
At the same time, Perez said, it reveals the progress of cooperation between the scientific communities of the two countries and may be the beginning of a more dynamic process of mutual drug registrations in both Belarus and Cuba. (Source: Granma)
